XML 72 R48.htm IDEA: XBRL DOCUMENT v3.7.0.1
Derivative Instruments (Tables)
 12 Months Ended
Dec. 31, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule Of Derivative Instruments, Fair Value
The following table presents the fair values of derivative instruments included in the consolidated balance sheets as of December 31, 2016 and 2015: 
 
 
 
 
(Liability) Asset Derivatives
 
 
 
 
Fair Value
Type of Derivative
 
Balance Sheets Location
 
2016
 
2015
Derivatives designated as hedging instruments
 
 
 
 
 
 
Forward contracts
 
Other receivables
 
$
—

 
$
454

 
 
Accrued payroll and other liabilities
 
(100
)
 
—

2013 Cross-currency interest rate swap (i)
 
Derivative instruments
 
(3,274
)
 
4,615

2016 Cross-currency interest rate swap (i)
 
Derivative instruments
 
(27,217
)
 
—

 
 
 
 
(30,591
)
 
5,069

(i) At December 31, 2016, presented in the consolidated balance sheet as follows: $19,876 as a current liability a
$10,615 as a non-current liability. At December 31, 2015, presented in the consolidated balance sheet as follo
$6,741 as a non-current asset and $2,126 as a current liability.
Schedule Of Cash Flow Hedges Included In Accumulated Other Comprehensive Income (Loss)
The following table presents the pretax amounts affecting income and other comprehensive income for the fiscal years ended December 31, 2016, 2015 and 2014 for each type of derivative relationship:
 
 
Forward contracts
 
Cross-currency interest rate swaps
 
Total
Derivatives in Cash Flow
Hedging Relationships
 
2016
 
2015
 
2014
 
2016
 
2015
 
2014
 
2016
 
2015
 
2014
(Loss) Gain Recognized in Accumulated OCI on Derivative (Effective Portion)
 
$
(1,861
)
 
$
1,903

 
$
1,925

 
$
(16,952
)
 
$
18,584

 
$
3,233

 
$
(18,813
)
 
$
20,487


$
5,158

Loss (Gain) Reclassified from Accumulated OCI into Income (Effective Portion) (i)
 
1,307

 
(2,306
)
 
(1,451
)
 
9,935

 
(11,903
)
 
(1,341
)
 
11,242

 
(14,209
)

(2,792
)
Loss Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing and Ineffective Portion) (ii)
 
—

 
—

 
—

 
—

 
(2,650
)
 
—

 
—

 
(2,650
)

—


(i) The (loss) gain recognized in income related to forward contracts was recorded as an adjustment to food and paper. The net (loss) gain recognized in income related to the cross-currency interest rate swap is presented in the consolidated income (loss) statement as follows: a (loss) gain of ($6,997), $13,595 and $5,084 for the fiscal year 2016, 2015 and 2014, respectively, as an adjustment to foreign exchange results and a loss of $2,938, $1,692 and $3,743, for the fiscal years 2016, 2015 and 2014, respectively, as an adjustment to net interest expense.
(ii)
In the fiscal year 2015 related to the loss incurred in connection with the amendment of the cross-currency interest rate swap agreement. These results were recorded within “Loss from derivative instruments” in the Company’s consolidated statements of income (loss).
Derivative Instruments, Gain (Loss)
The following table presents the pretax amounts affecting income for the fiscal year ended December 31, 2016:

 
 
2016
 
Derivatives in Fair Value Hedging Relationships
 
Loss recognized in Income on hedging derivatives
 
Gain recognized in Income on hedging items
 
 
 
 
 
 
 
 
Cross-currency swaps (i)
 
(5,814
)
 
2,877

 

(i)
The loss amounting to $2,938, related to the ineffective portion of derivatives, was recorded within “Loss from derivative instruments” in the Company’s consolidated statements of income (loss).
Schedule Of Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance
 
 
 
Loss Recognized in Income on Derivative instruments
Derivatives Not Designated as Hedging Instruments
Location of Loss Recognized in Income
 
2016
 
2015
 
2014
Total equity return swap
General and administrative expenses (i)
 
$
—

 
$
(1,743
)
 
$
(6,861
)
 
Net interest expense
 
—

 
(453
)
 
(360
)
Others
Loss from derivative instruments
 
(127
)
 
(244
)
 
(685
)
Total
 
 
$
(127
)
 
$
(2,440
)
 
$
(7,906
)

(i)
For the fiscal year 2015, includes a loss amounting to $1,252 excluded from Adjusted EBITDA as from the total vesting of the plan. See Adjusted EBITDA reconciliation in Note 21.